Uniseed and MRCF have become founding investors in University of Melbourne's precision medicine spinout Certa Therapeutics.

Certa Therapeutics, a Australia-based precision medicine spinout from University of Melbourne, obtained A$25m ($18.5m) today in a founding round backed by multi-university venture fund Uniseed.
Uniseed was joined in the round by the Australian government-backed Medical Research Commercialisation Fund (MRCF), which aims to advance technologies emerging from Australia’s medical research institutes and affiliated research hospitals.
MRCF invested $16.3m on behalf of the Australian government’s Biotechnology Translation Fund. Uniseed provided a $2.2m sum, $1.5m of which came from its…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?